Read an analysis on two dividend stocks with growth potential and inflation protection, designed to thrive in today's market ...

At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...

The FTSE 100 is expected to remain a battleground between buyers and sellers on a busy day for corporate reporting.

Artificial intelligence (AI) investing has been a major theme in the markets in 2023 and 2024, and will likely be a trend in ...

Asset & Wealth Management - another area where Goldman has traditionally been strong - also did well with revenue rising 16% ...

One of AB InBev's subsidiaries is another five-star stock, Ambev, the largest brewer in Latin America and the Caribbean. Like ...

I’ve been talking a lot with a weather predicting outfit called Weathertrends360 and their boss Bill Kirk. We were talking ...

Your retirement portfolio shouldn’t be more than 60% invested in stocks, even if you plan to be working for another 30 or 40 ...

After explosive gains yesterday, Rocket Lab (NASDAQ: RKLB) stock is coming down to Earth a bit in Thursday's trading. The ...

Before you jump into buying stock, first take the time to learn what type of broker-dealer relationship may be right for you.

Electric vehicle stocks are falling Thursday after a report detailed the incoming Trump administration’s plans to axe a tax ...

Saudi Arabia’s wealth fund sold part of its stake in the kingdom’s main mobile-phone operator for about $1 billion, the ...